SLCO1B1 and rhabdomyolysis: This case illustrated the clinical relevance of the relationship between pharmacogenetics (low activity transporter OATP1B1 and low activity enzyme CYP2C19) and DDI between atorvastatin and a PPI (pantoprazole) in the development of rhabdomyolysis with acute renal failure.